Difference between revisions of "Minutes - Medication WG 2022-02-15"

From Health Level 7 Belgium Wiki
Line 34: Line 34:
 
===== '''Agenda''' =====
 
===== '''Agenda''' =====
 
* presentation and discussion on drug databases
 
* presentation and discussion on drug databases
 +
  
 
===== '''Minutes''' =====
 
===== '''Minutes''' =====
Line 40: Line 41:
 
::::* BCFI was structured in a Repertorium drug tables
 
::::* BCFI was structured in a Repertorium drug tables
 
::* SAM is a consortium: APB, RIZIV, FOD VG, FAGG to put all drugs in one database
 
::* SAM is a consortium: APB, RIZIV, FOD VG, FAGG to put all drugs in one database
::::* VMP, VMP-groups are concepts were implemented through guidance from BCFI
+
::::* VMP, VMP-groups are concepts that were implemented through guidance from BCFI
::* [https://samviewer.digile.be/nl/sam public SAM viewer] was developed by Digile, visualisation in an intuitive manner that has the full SAMv2 content (2 updates a day - not realtime), is public
+
::* [https://samviewer.digile.be/nl/sam the public SAM viewer] was developed by Digile, visualisation in an intuitive manner that has the full SAMv2 content (2 updates a day - not realtime), search is intuitive by brand, substance, code (CTI-extended, CNK), has the business history
::::* feedback option is available as there are still some data quality issues & inconsistencies with SAM
+
::::* feedback option is available for the pharma and industry as there are still some data quality issues & inconsistencies with SAM
::::* difficult follow-up on raised issues  
+
::::::* follow-up on raised issues is still difficult
::::* overview of VOs-groups to improve easier access to these data that was not open to the public before
+
::::* CSV experts are available f.e. for overview of VOS-groups to improve easier access to these data that was not open to the public before
 
::* ISO IDMP gap analysis on SAM V2 has been done  
 
::* ISO IDMP gap analysis on SAM V2 has been done  
 
::::* ISO IDMP does not present a fixed vocabulary
 
::::* ISO IDMP does not present a fixed vocabulary
::::* objective is to map SAMv2 to ISO IDMP database, works quite well although there are no identifiers in the 2 sytems
+
::::* objective is to map SAMv2 to ISO IDMP database, works quite well although there are no identifiers in the 2 systems
 
::::* attributes can be useful for the mapping
 
::::* attributes can be useful for the mapping
* How can we query with FHIR on SAMv2 ?
+
* How can we query with FHIR on SAMv2 ? There is a restful API but not on FHIR
 
::* f.e. if doctor wants to query on substance
 
::* f.e. if doctor wants to query on substance
 
::* what are the logical models behind: see https://www.samportal.be/nl/sam/documentation PIM logical model
 
::* what are the logical models behind: see https://www.samportal.be/nl/sam/documentation PIM logical model
* Concept of VMP group: it is a clinical concept
+
* what is a VMP group: it is a clinical concept for medicinal products having the same substance, strength, pharmaceutical form and route of administration - seen from the point of view of a clinician (doctor, pharmacist)
::* to add
+
* VMP is a more regulatory concept
* VMP is more a regulatory concept
+
* our WG goal: how to represent medication in a medication scheme - which recommendation to represent the medication ? The current MS is focused on brand name ; VOS-group of substance seems better from a clinical point of view as it includes the route of administration
* our WG goal: how to represent medication in a medication scheme - which recommendation is there ? current MS is focused on brand name, VOS-group of substance seems better from a clinical point of view of VMP-group as it includes the route of administration
 
 
::* RIZIV wants a different view so both levels will have to be there (packages)
 
::* RIZIV wants a different view so both levels will have to be there (packages)
  
 
+
* The VIDIS project would like to have first artefacts of our WG  
 
+
::* medication treatment line are being worked on - we need some use cases/examples to make progress - will be ready for next meeting
 
+
* We have started working on [https://docs.google.com/document/d/1rTGHvdNMZfR4MZvVVIfUnoAi8eDQsYTpcKBB3B8q4JI/edit# a document listing different concepts] that will be used in the medication scheme. This document will be presented in next meeting
 
 
* VIDIS would like to have first artefacts of our WG  
 
::* medication treatment line are being worked on  
 
* We have started working on [https://docs.google.com/document/d/1rTGHvdNMZfR4MZvVVIfUnoAi8eDQsYTpcKBB3B8q4JI/edit# a document listing different concepts] that will be used in the medication scheme, how we consist
 
  
  
 
'''Action items for next meeting'''
 
'''Action items for next meeting'''
 
* José to work on use cases and add medication view line in view and how it all works at operational level
 
* José to work on use cases and add medication view line in view and how it all works at operational level
* Jens to start writing up document
 
  
 +
'''Agenda items for next meeting'''
 +
* medication treatment line examples
 +
* discuss document
 
'''Next meeting March 1 at 11AM'''
 
'''Next meeting March 1 at 11AM'''

Revision as of 11:57, 15 February 2022

Attendees
  • An Crepel, digile
  • Annemieke Vergauwe
  • Bart Decuypere
  • Jan Lenie
  • Jean-Michel Polfliet
  • Jens Penny
  • José Costa Teixeira
  • Karlien Erauw
  • Kris Deceunynck
  • Pablo Christiaens
  • Thomas Van Langendonck
  • Tom Henkens
Excused/Not present
  • Anne Nerenhausen
  • Bruno Casneuf
  • Dieter Sauvillers
  • Elhassan Baazizi
  • Hanne Vuegen
  • Jean-Louis Maggetto
  • Jeroen De Wilde
  • Katrien Thorré
  • Lars Vanreppelen
  • Marc Buckens
  • Nick Hermans
  • Nils Devos
  • Richard Francken
  • Thomas Van Langendonck
  • Tom De Backer
  • Walter Bollaert
  • Will van Norel
Agenda
  • presentation and discussion on drug databases


Minutes
  • An from Digile has worked on the SAM database and has plenty of drug data expertise
  • BCFI, the green booklet used by pharmacists & doctors
  • BCFI was structured in a Repertorium drug tables
  • SAM is a consortium: APB, RIZIV, FOD VG, FAGG to put all drugs in one database
  • VMP, VMP-groups are concepts that were implemented through guidance from BCFI
  • the public SAM viewer was developed by Digile, visualisation in an intuitive manner that has the full SAMv2 content (2 updates a day - not realtime), search is intuitive by brand, substance, code (CTI-extended, CNK), has the business history
  • feedback option is available for the pharma and industry as there are still some data quality issues & inconsistencies with SAM
  • follow-up on raised issues is still difficult
  • CSV experts are available f.e. for overview of VOS-groups to improve easier access to these data that was not open to the public before
  • ISO IDMP gap analysis on SAM V2 has been done
  • ISO IDMP does not present a fixed vocabulary
  • objective is to map SAMv2 to ISO IDMP database, works quite well although there are no identifiers in the 2 systems
  • attributes can be useful for the mapping
  • How can we query with FHIR on SAMv2 ? There is a restful API but not on FHIR
  • what is a VMP group: it is a clinical concept for medicinal products having the same substance, strength, pharmaceutical form and route of administration - seen from the point of view of a clinician (doctor, pharmacist)
  • VMP is a more regulatory concept
  • our WG goal: how to represent medication in a medication scheme - which recommendation to represent the medication ? The current MS is focused on brand name ; VOS-group of substance seems better from a clinical point of view as it includes the route of administration
  • RIZIV wants a different view so both levels will have to be there (packages)
  • The VIDIS project would like to have first artefacts of our WG
  • medication treatment line are being worked on - we need some use cases/examples to make progress - will be ready for next meeting


Action items for next meeting

  • José to work on use cases and add medication view line in view and how it all works at operational level

Agenda items for next meeting

  • medication treatment line examples
  • discuss document

Next meeting March 1 at 11AM